H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.184 HKD -0.54%
Market Cap: 92.1m HKD
Have any thoughts about
Huakang Biomedical Holdings Co Ltd?
Write Note

Huakang Biomedical Holdings Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Huakang Biomedical Holdings Co Ltd
Operating Income Peer Comparison

Comparables:
K
876
K
1134
1120
O
6929

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Operating Income
-ÂĄ6.4m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Kaisa Health Group Holdings Ltd
HKEX:876
Operating Income
-HK$52.1m
CAGR 3-Years
-6%
CAGR 5-Years
-22%
CAGR 10-Years
-6%
K
Kelfred Holdings Ltd
HKEX:1134
Operating Income
-HK$13m
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arts Optical International Holdings Ltd
HKEX:1120
Operating Income
HK$34.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-1%
O
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Operating Income
$39.4m
CAGR 3-Years
79%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Huakang Biomedical Holdings Co Ltd's Operating Income?
Operating Income
-6.4m CNY

Based on the financial report for Dec 31, 2023, Huakang Biomedical Holdings Co Ltd's Operating Income amounts to -6.4m CNY.

What is Huakang Biomedical Holdings Co Ltd's Operating Income growth rate?
Operating Income CAGR 3Y
7%

Over the last year, the Operating Income growth was -51%. The average annual Operating Income growth rates for Huakang Biomedical Holdings Co Ltd have been 7% over the past three years .

Back to Top